These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15331554)

  • 1. Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors.
    Zheng F; Cornacchia F; Schulman I; Banerjee A; Cheng QL; Potier M; Plati AR; Berho M; Elliot SJ; Li J; Fornoni A; Zang YJ; Zisman A; Striker LJ; Striker GE
    Diabetes; 2004 Sep; 53(9):2420-7. PubMed ID: 15331554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
    Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
    FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy.
    Yang G; Cheng Q; Liu S; Zhao J
    PLoS One; 2015; 10(9):e0137245. PubMed ID: 26340671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
    Moriyama T; Oka K; Ueda H; Imai E
    Clin Exp Nephrol; 2004 Sep; 8(3):230-6. PubMed ID: 15480900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
    Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
    Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
    Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.
    Cohen MP; Masson N; Hud E; Ziyadeh F; Han DC; Clements RS
    Exp Nephrol; 2000; 8(3):135-43. PubMed ID: 10810230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy.
    Awazu M; Omori S; Ishikura K; Hida M; Fujita H
    J Am Soc Nephrol; 2003 Mar; 14(3):699-708. PubMed ID: 12595506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors.
    Cornacchia F; Fornoni A; Plati AR; Thomas A; Wang Y; Inverardi L; Striker LJ; Striker GE
    J Clin Invest; 2001 Dec; 108(11):1649-56. PubMed ID: 11733560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells.
    Mishra R; Emancipator SN; Kern T; Simonson MS
    Kidney Int; 2005 Jan; 67(1):82-93. PubMed ID: 15610231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
    Zhao HJ; Wang S; Cheng H; Zhang MZ; Takahashi T; Fogo AB; Breyer MD; Harris RC
    J Am Soc Nephrol; 2006 Oct; 17(10):2664-9. PubMed ID: 16971655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.
    Guo M; Ricardo SD; Deane JA; Shi M; Cullen-McEwen L; Bertram JF
    J Anat; 2005 Dec; 207(6):813-21. PubMed ID: 16367807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic kidney disease in the db/db mouse.
    Sharma K; McCue P; Dunn SR
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1138-44. PubMed ID: 12736165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance.
    Østergaard MV; Pinto V; Stevenson K; Worm J; Fink LN; Coward RJ
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F312-F321. PubMed ID: 27852608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
    Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
    J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
    Ziyadeh FN; Hoffman BB; Han DC; Iglesias-De La Cruz MC; Hong SW; Isono M; Chen S; McGowan TA; Sharma K
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8015-20. PubMed ID: 10859350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.
    Flyvbjerg A; Dagnaes-Hansen F; De Vriese AS; Schrijvers BF; Tilton RG; Rasch R
    Diabetes; 2002 Oct; 51(10):3090-4. PubMed ID: 12351452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.